4D Molecular Therapeutics, Inc. Common Stock

FDMTNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
11.60 USD
↗ 0.08 (0.69%)AT CLOSE (11:59 AM EDT)
11.36
↘ 0.24 (2.07%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
11.36
↘ 0.24 (2.07%)
🔴Market: CLOSED

Shares of 4D Molecular Therapeutics, Inc. Common Stock (FDMT) are trading at $11.60. FDMT shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place FDMT at a fair price relative to peers.

Technical & fundamental data as of Jun 26, 2026.

Open?$11.49
High?$12.04
Low?$10.85
Prev. Close?$11.52
Volume?2.0M
Avg. Volume?934.9K
VWAP?$11.36
Rel. Volume?2.16x
Bid / Ask
Bid?$11.37 × 400
Ask?$12.20 × 100
Spread?$0.83
Midpoint?$11.79
Valuation & Ratios
Market Cap?606.4M
Shares Out?52.3M
Float?50.4M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?1.34
EPS?-$3.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Clinical-Stage Platforms
Employees
196
Market Cap
602.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.4dmoleculartherapeutics.com
Listed
2020-12-11
Address
5858 HORTON STREET #455
EMERYVILLE, CA 94608
Phone: (510) 505-2680
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
87
Momentum?
45
Short Sent.?
5
Piotroski F-Score?1/9Weak
Altman Z-Score?3.68Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?25.64%Squeeze Risk
Short Interest?12.9M
Days to Cover?16.5
Free Float50.4M
Avg Daily Volume782.4K
Settlement Date2026-06-15
Financial Health
Current Ratio?9.34Strong
Quick Ratio?9.34Strong
Cash Ratio?1.67Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
91
1.34CHEAP▾
P/S?
Peers
100
S&P
18
6.87FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.1CHEAP▾
EV/Sales?
Peers
100
S&P
27
6.05HIGH▾
Returns & Efficiency
ROE?
S&P
5
-35.6%WEAK▾
ROA?
S&P
3
-31.4%WEAK▾
Cash Flow & Enterprise
FCF?$-129544000
Enterprise Value?$533.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist